Offer - Urjas Oil for just ₹ 1 X
Eliquis 2.5 Mg Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Deep Vein Thrombosis. Other than this, Eliquis 2.5 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Eliquis 2.5 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Eliquis 2.5 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Eliquis 2.5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Eliquis 2.5 Mg Tablet is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Eliquis 2.5 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Eliquis 2.5 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bleeding, Liver Disease, Heart Disease are examples of such conditions. The section on Eliquis 2.5 Mg Tablet contraindications lists all such conditions.
Additionally, Eliquis 2.5 Mg Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Eliquis 2.5 Mg Tablet is not safe while driving, and is not addiction.
Eliquis 2.5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Eliquis 2.5 Mg Tablet safe for pregnant women?
Eliquis can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Eliquis right away. Take your doctor's advice before taking it again.
Is the use of Eliquis 2.5 Mg Tablet safe during breastfeeding?
Eliquis can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Eliquis 2.5 Mg Tablet on the Kidneys?
Eliquis has very mild side effects on the kidneys.
What is the effect of Eliquis 2.5 Mg Tablet on the Liver?
There are no any side effects of Eliquis on the liver.
What is the effect of Eliquis 2.5 Mg Tablet on the Heart?
Eliquis has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Eliquis 2.5 Mg Tablet unless your doctor advises you to do so -
Is this Eliquis 2.5 Mg Tablet habit forming or addictive?
Eliquis 2.5 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Eliquis 2.5 Mg Tablet, you should not drive or work on any heavy machine, as Eliquis 2.5 Mg Tablet can make you drowsy.
Is it safe?
Yes, Eliquis 2.5 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Eliquis 2.5 Mg Tablet for mental disorders.
Interaction between Food and Eliquis 2.5 Mg Tablet
It is safe to take Eliquis 2.5 Mg Tablet with food.
Interaction between Alcohol and Eliquis 2.5 Mg Tablet
It is difficult to say anything about the effect of Eliquis 2.5 Mg Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Eliquis (apixaban)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 178-180